Results 121 to 130 of about 2,120,047 (374)

Advances and Outlook of Nickel‐Based MOFs–LDHs Materials for Energy Conversion

open access: yesAdvanced Sustainable Systems, EarlyView.
In this graphical abstract, we present the pivotal gap between the activity and stability parameters as far as intergrated Ni‐based MOF/LDF electrocatalysts are concerned. For large scale application, these two parameters should be optimized and furthermore balanced in order to promote sustainable electrocatalytic hydrogen production.
Lincoln Einstein Kengne Fotso   +4 more
wiley   +1 more source

Hemorrhagic Sudden Onset of Spinal Epidural Angiolipoma

open access: yesCase Reports in Orthopedics, 2018
Angiolipomas are relatively rare benign tumors. Spinal angiolipomas that generally induce slow progressive cord compression are most commonly found in the thoracic region. A 49-year-old female with obesity presented with a 1-week history of progressively
Kiyotaka Horiuchi   +4 more
doaj   +1 more source

Effect of laminin 332 on motility and invasion in bladder cancer

open access: yesKaohsiung Journal of Medical Sciences, 2013
We examined the correlation between laminin 332 and malignancy in bladder cancer patients, and, using a strain of invasive bladder cancer cells, determined whether laminin 332 causes bladder cancer motility and invasion.
Sung-Gu Kang   +11 more
doaj   +1 more source

Paper 332

open access: yes
Student response paper submitted for course ACA-401/ACA-401D.
openaire   +2 more sources

Rewiring Neuroimmunity: Nanoplatform Innovations for CNS Disease Therapy

open access: yesAdvanced Therapeutics, EarlyView.
This review explores emerging nanoplatform strategies designed to modulate neuroimmune responses for treating central nervous system (CNS) disorders. It examines structural and microenvironmental barriers, advances in multifunctional and targeted nanotechnologies, and highlights clinical progress and translational challenges, offering insights into the
Muhammad Usman Akbar   +7 more
wiley   +1 more source

Exploring AAV‐Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential

open access: yesAdvanced Science, EarlyView.
Current preclinical studies of AAV‐mediated gene therapy explore different strategies based on the characteristics of inner ear diseases. For genetic hearing loss, approaches include the replacement of a “good gene,” removal of a “bad gene,” or direct correction of mutations through base editing.
Fan Wu   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy